NeuroPace, Inc.
Martha Morrell (CHIEF MEDICAL OFFICER) reports NPCE insider transactions
About this filing
NeuroPace, Inc. (NPCE) filed Form 4 (insider transaction) with the SEC on Sep 25, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Martha Morrell · CHIEF MEDICAL OFFICER
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | F · tax withholdingFootnotes F1 | −335 | $13.97 | $4,679.95 | 51,357 | Direct |
Footnotes
- F1 Represents the number of shares withheld by the Issuer on September 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.
More NPCE filings
- 4
Filed Nov 18, 2026
- 4
Filed Nov 17, 2026
- 4
Filed Nov 17, 2026
- 10-Q
Filed Nov 12, 2026
- 8-K
Filed Nov 12, 2026
- 4
Filed Sep 21, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.